Viewing Study NCT01119794

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-05-15 @ 6:00 PM
Study NCT ID: NCT01119794
Status: TERMINATED
Last Update Posted: 2015-08-26
First Post: 2010-05-06
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab
Sponsor: Brown University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma, Non-Hodgkins View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell small lymphocytic lymphoma View
None marginal zone lymphoma View
None follicular lymphoma View
None mantle cell lymphoma View
None Waldenström macroglobulinemia. View
None Low Grade B cell Non-Hodgkins Lymphoma View